CCCure is committed to supporting research which aligns with our dual aims of optimising care now and being instrumental in cure. At CCCure, whilst we undertake significant internal research, we welcome collaboration from others to help advance IBD care.










As leaders in IBD care and advocacy, CCCure and our collaborators are actively involved in a wide range of research activities to achieve our dual aims of optimising care now and being instrumental in cure.
None
2025
Jane M Andrews
COI Declaration for ECCO 2025: Speaker‘s fees, research support, Ad Boards, industry consultation within last 3 years: Abbvie, BMS, Celgene, Celltrion, Falk, Ferring, Fresenius Kabi, Gilead, Janssen, J&J, MSD/Organon, Nestle, Novartis, Pfizer, Sandoz, Shire, Takeda, Vifor, Royal Adelaide Hospital Research Fund, The Hospital Research Fund 2020-2025, The Helmsley Trust 2020-2026.
2025
None
2025
None
2025
None
2025
I have received honoraria or consulting fees from Abbvie, Janssen, Takeda, Pfizer, Ferring, Bristol Myers Squibb, Gilead, Tillott’s, Sandoz, Celltrion, Chiesi, Dr Falk, Microba, Glaxo Smith Klein, Antara, Suono, Therpeutic Guidelines, Research Review,Grants: NHMRC, US Department of Defence, The Gutsy Foundation, The Gastroenterological Society of Australia, The University of Queensland, The Viertel Foundation, and The Mater Foundation
2025
None
2025
None
2025
Ad Boards: Abbvie, Amgen, BMS, Celltrion, Eli Lilly, Ferring, GSK, Janssen, Organon, Pfizer, TakedaSpeaker Fees: Cornerstones Health, Dr Falk, Ferring, Janssen, Sandoz, Sydney IBD School, TakedaEducational Support: DrFalk, Sandoz, TakedaResearch Support: Abbvie, Agency for Clinical Innovation, Amgen, BMS, Chiesi, Celltrion, DrFalk, Ferring, Janssen, Medical Research Future Fund, Pfizer, South Western Sydney Local Health District, Sydney Partnership for Health, Research and Enterprise, Takeda and The Leona M and Harry B Helmsley Charitable Trust
2025
None
2025
Advisory committee member and conference sponsorship: Dr Falk Pharma Australia Pty Ltd, Ferring Pharmaceuticals Pty LtdAdvisory committee member: Abbvie
2025
None
2025
Simon Ghaly has received speaker fees, research grants and travel grants from Dr. Falk pharma, Janssen, Pfizer, Abbvie, Sandoz, and Ferring and served on advisory boards for Pfizer and Abbvie.
2025
Speaker Fees: Takeda, Janssen, Nutricia, Aspen Nutritionals, Abbvie, Evolution HealthConsultancy Fees: Abbvie, Janssen
2025
None
2025
None
2025
None
2025
Yoon-Kyo An has received consulting and speaker fees from AbbVie, Allimentiv, Bristol Myers Squibb, Eli Lilly, Dr Falk, Ferring, Glaxo-Smith Kline, Janssen, Pfizer, Samsung, Sandoz, Shire, and Takeda Pharmaceuticals; advisory board fees from AbbVie, Bristol Myers Squibb, Chiesi, Janssen, Microba, NPS Medicine Wise, the Council of Therapeutic Advisory Group (CATAG), Takeda Pharmaceuticals and Xencor; and research and educational support from AbbVie, Bristol Myers Squibb, Cannon, Celltrion, Chiesi, Dr Falk, Ferring, Janssen, Pfizer, Samsung, Sandoz, Siemen, and Takeda Pharmaceuticals.
2025
None
2025
Kate Lynch has received speaker honoraria, advisory board fees, and/or conferencetravel/registration support from AbbVie, Bristol-Myers Squibb (BMS), Chiesi, Dr. Falk,Ferring, Gilead, Guidepoint, Intercept Pharmaceuticals, Janssen-Cilag, Merck Sharp &Dohme (MSD), Norgine, Pfizer, Pliant, Sandoz, Takeda, and the Royal Adelaide Hospital(RAH) Research Fund.
2025
None
2025
None
2025
Educational and research funding from Jansen, Abbvie, Ferring, Takeda, Pfizer
2025
Conference travel/registration from Gilead, MSD, Johnson & Johnson and Abbvie
2025
Conference Sponsorship: Dr Falk Pharma Australia Pty Ltd, Ferring Pharmaceuticals Pty LtdCCCure Head of Operations & Company Secretary at the time of research and analysis
2025
None
2025
None
2025
None
2025
None
2025
Advisory Board: Janssen, TakedaSpeaker Fees: Janssen, Takeda, Glaxo Smith Kline (GSK)
2025
G.W. has received speaker fees, educational support, advisory boards and research grants from Dr Falk Pharma, Janssen, Takeda, Ferring, Celltrion, Sandoz and Abbvie
2025
Conference travel/registration support from Dr Falk
2025
None
2025

CCCure is a registered company in Australia, operating under [State Name], AUS (Registration No. XX-987654). The company is authorized and regulated by the [State Department of Health Services] in accordance with the [Health and Wellness Services Act], License No. [ABC-123456]. All medical services provided by CCCure are subject to state oversight and follow all applicable healthcare regulations.